Hiroki Hashida
Impact in
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
- Oncology top 2%
- Chemokine receptors and signaling
- Cancer Cells and Metastasis
- Peptidase Inhibition and Analysis
- Pancreatic and Hepatic Oncology Research
Papers in
- Co-authors
- Arimichi Takabayashi (13 shared papers)Masayuki Miyake (9 shared papers)Masashi Adachi (6 shared papers)Toshihiko Taki (5 shared papers)Takanori Kitamura (3 shared papers)Makoto M. Taketo (3 shared papers)Masahiro Aoki (3 shared papers)Yoshio Yamaoka (4 shared papers)
- Journals
- International Journal of Cancer (2 papers)Journal of Clinical Oncology (2 papers)ESMO Open (2 papers)Surgery Today (2 papers)British Journal of Cancer (2 papers)
- Partner nations
- JapanChinaSwitzerland
In The Last Decade
Hiroki Hashida
56 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 87
- Immunology and Allergy 252
- Oncology 904
- Cancer Research 297
- Immunology 351
- Molecular Biology 661
Countries citing papers authored by Hiroki Hashida
This map shows the geographic impact of Hiroki Hashida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Hashida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Hashida more than expected).
Fields of papers citing papers by Hiroki Hashida
This network shows the impact of papers produced by Hiroki Hashida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Hashida. The network helps show where Hiroki Hashida may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroki Hashida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 275 | |
| 2 | 2007 | 241 | |
| 3 | 2002 | 190 | |
| 4 | 2011 | 175 | |
| 5 | Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. | 2003 | 175 |
| 6 | 2010 | 150 | |
| 7 | 2003 | 110 | |
| 8 | 1998 | 108 | |
| 9 | 2001 | 52 | |
| 10 | 2000 | 46 | |
| 11 | 2001 | 38 | |
| 12 | 2007 | 31 | |
| 13 | 2015 | 25 | |
| 14 | 2018 | 24 | |
| 15 | 2015 | 19 | |
| 16 | 2017 | 16 | |
| 17 | 2022 | 14 | |
| 18 | 2001 | 13 | |
| 19 | 2019 | 12 | |
| 20 | 2018 | 10 |
About Hiroki Hashida
Hiroki Hashida is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Molecular Biology and Hepatology, having authored 59 papers that have together received 1.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Colorectal Cancer Surgical Treatments (5 papers), Gastric Cancer Management and Outcomes (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Cell Adhesion Molecules Research (4 papers) and Surgical site infection prevention (3 papers). The work is most often cited by research in Immunology and Allergy (252 citations), Oncology (904 citations), Cancer Research (297 citations), Immunology (351 citations) and Molecular Biology (661 citations). Hiroki Hashida has collaborated with scholars based in Japan, China and Switzerland. Frequent co-authors include Arimichi Takabayashi, Masayuki Miyake, Masashi Adachi, Toshihiko Taki, Takanori Kitamura, Makoto M. Taketo, Masahiro Aoki, Yoshio Yamaoka, Keiichi Kondo and Nobuoki Kohno. Their work appears in journals such as International Journal of Cancer, Journal of Clinical Oncology, ESMO Open, Surgery Today and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.